Mesoblast Cleared By FDA For Advanced Trials Of Back Pain Treatment Wall Street Journal AU) said Wednesday it has been cleared by the US Food & Drug Administration to begin an advanced clinical trial of its stem cell product to treat chronic low back pain . The company said in a statement the Phase 2 trial would build on pre-clinical … US Food and Drug Administration Clears Mesoblast Limited (ASX:MSB) Phase 2 ..
Read the original:
Mesoblast Cleared By FDA For Advanced Trials Of Back Pain Treatment – Wall Street Journal
